HEALTHSTAT NEWS
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
Eli Lilly is threatening to cut off price discounts from 340B hospitals that fail to submit required claims data, aiming to prevent duplicate discounts. The FDA is set to hold a closed-door meeting with rare disease advocates to discuss regulatory challenges for drug approvals.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
- ‘People should be talking about it’: moves to curtail vaccine information obscures important science, doctors say
- JD Vance threatens health funding to states that don’t comply with White House anti-fraud effort
- JD Vance holds chilling closed-door summit with America's most powerful men as horrifying global threat menacing hospitals spirals
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
- STAT+: FDA to reconsider treatment for rare cancer after surprise rejection